Company: HURA
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0000950170-25-108972
Chunk: 0

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-14
Form: 10-Q
Item: Item 1
Chunk 0
---
TuHURA Biosciences, Inc. 

Condensed Consolidated Balance Sheets

     June 30,

     December 31,

     2025

     2024

     (Unaudited)

     Assets

     Current Assets:

     Cash and cash equivalents
      
     $
     8,512,824

     $
     12,657,178

     Deposits, planned business acquisition (note 1)

     -

     5,994,503

     Stock subsciption receivable

     2,997,547

     -

     Other current assets

     1,029,088

     958,708

     Total Current Assets

     12,539,459

     19,610,389

     Property and equipment, net

     144,171

     123,366

     Operating right-of-use assets

     122,511

     199,160

     Other noncurrent assets

     -

     33,769

     Goodwill

     13,554,163

     -

     In-process research and development

     8,261,000

     -

     Total Assets
      
     $
     34,621,304

     $
     19,966,684

     Liabilities and Stockholders' Equity

     Current Liabilities:

     Accounts payable and accrued expenses
      
     $
     12,093,163

     $
     5,170,166

     Note Payable assumed from Kineta Merger

     434,000

     -

     Holdback liability

     2,519,644

     -

     Lease liabilities, current

     124,969

     159,844

     Total Current Liabilities

     15,171,776

     5,330,010

     Long-term Liabilities:

     Lease liability, long term

     -

     42,698

     Total Liabilities

     15,171,776

     5,372,708

     Stockholders' Equity:

     Preferred Stock Series A (assumed in Kintara merger); $1.00 par value, 278,530 shares   outstanding as of June 30, 2025 and December 31, 2024

     278,530

     278,530

     Common stock, $0.001 par value, 200,000,000